Rebimastat had been in phase II/III clinical trials for the treatment of non small cell lung cancer. Reference standards of Rebimastat API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Rebimastat
Catalogue No.:PA 18 91000
CAS :
Molecular Formula : C23H41N5O5S
Molecular Weight : 499.67
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
